bioRxiv
Elexacaftor/tezacaftor/ivacaftor treatment is associated with epigenetic age deceleration in cystic fibrosis
Preprint: non-randomised trial in 8 peopleInterventions
1 year
Abstract
Background: Cystic fibrosis (CF) is associated with chronic inflammation and progressive multisystem disease, which may contribute to accelerated biological aging.
The paper
University of British Columbia
bioRxiv, 18 Sep 2026, CC BY, Preprint, not peer-reviewed
